A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07138209 · RECRUITING
Trial details
- NCT number
- NCT07138209
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-07
- Primary completion
- 2027-12-01
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.